Global Neurological Biomarkers Market to Grow 15.48% by 2020 - Key Vendors are Myriad RBM, Proteome Sciences & QIAGEN - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Neurological Biomarkers Market 2016-2020" report to their offering.

The report forecasts the global neurological biomarkers market to grow at a CAGR of 15.48% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the key drivers for market growth will be increasing focus toward drug discovery applications. Close to 1% of medications in the biomarker discovery and development pipeline achieve the commercial success. The rate of failure cases is too high, and very frequently drug candidates fail in the late development phase. This has led to the evolution of alternative biomarker-based techniques by contract research organizations and manufacturers.

Further, the report states that unmet market needs will be a challenge for the market.

Key questions answered in this report:

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Key vendors:

• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific
  

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by indication

PART 07: Market segmentation by application

PART 08: Market segmentation by services

PART 09: Market segmentation by end-user

PART 10: Geographical segmentation

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

PART 17: Key vendor analysis

PART 18: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/w8n68z/global

Related Topics: Biomarkers